SM 10906

Drug Profile

SM 10906

Alternative Names: SM-10906

Latest Information Update: 30 Aug 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sumitomo Pharmaceuticals
  • Class Antiplatelets
  • Mechanism of Action Collagenase stimulants; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Blood coagulation disorders; Hypertrophic scars

Most Recent Events

  • 07 Jan 2004 No development reported - Preclinical for Coagulation disorders in Japan (unspecified route)
  • 28 Jun 2001 No-Development-Reported for Hypertrophic scars in Japan (Unknown route)
  • 19 Jan 1998 Preclinical development for Hypertrophic scars in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top